Patient and Healthcare Provider Resource

Patient and Healthcare Providers Resource

IVCancerEdSheets.com, Patient + Healthcare Providers Resource

IVCancerEdSheets.com, the Patient and Healthcare Providers Resource

AC Doxorubicin and Cyclophosphamide
7+3 (Idarubicin)
7+3 and GO
AAVD
Ado-Trastuzumab Emtansine
Albumin-bound Paclitaxel and Gemcitabine
Atezolizumab
Atezolizumab plus Bevacizumab
Avelumab
Azacitidine
Belantamab Mafodotin
Belinostat
Bendamustine and Polatuzumab Vedotin + Rituximab
Bendamustine and Rituximab
Bevacizumab
Bleomycin, Etoposide, and Cisplatin (BEP)
Blinatumomab
Bortezomib
Brentuximab Vedotin
Cabazitaxel
Capecitabine and Oxaliplatin
Carboplatin
Carboplatin and Gemcitabine
Carboplatin and Paclitaxel
CaRD
Cemiplimab
Cetuximab
Chop
Cisplatin
Cyclophosphamide, Methotrexate, and Fluorouracil (CMF)
Cytarabine and Daunorubicin (7+3)
DA-EPOCH-R
DD-MVAC
Decitabine
Dexamethasone, Cytarabine and Cisplatin (DHAP)
DHAX
DHAX + Rituximab
Docetaxel
Docetaxel and Cyclophosphamide (TC)
Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab (TCHP)
Dose-dense Doxorubicin and Cyclophosphamide (ddAC)
Dostarlimab
Doxorubicin Hydrochloride, Bleomycin Sulfate, Vinblastine Sulfate and Dacarbazine (ABVD)
Doxorubicin Liposomal
Durvalumab
Durvalumab, Gemcitabine and Cisplatin
Enfortumab Vedotin
Eribulin mesylate
Eribulin Mesylate and Margetuximab
ESHAP
ESHAP + Rituximab
Fam-Trastuzumab Deruxtecan-Nxki
FLAG
FLAG-IDA
FLOT
Fluorouracil, Cisplatin, and Trastuzumab
Fluorouracil, Cisplatin, Trastuzumab, and Pembrolizumab
FOLFIRI
FOLFIRI + Cetuximab
FOLFIRI + Panitumumab
Folfirinox
FOLFOX
FOLFOX + Trastuzumab
FOLFOX + Trastuzumab and Pembrolizumab
FOLFOX and Bevacizumab
GDP
GDP+R
Gemcitabine
Gemcitabine and Cisplatin
Gemcitabine and Oxaliplatin (GemOx)
Gemcitabine and Oxaliplatin (GemOx) + Rituximab
High Dose Cytarabine (“HiDAC”) and Idarubicin
High-Dose Cytarabine (“HiDAC”) and Daunorubicin
Ifosfamide, Carboplatin and Etoposide (ICE)
Ifosfamide, Carboplatin, Etoposide + Rituximab (ICE+R)
Inotuzumab Ozogamicin
Ipilimumab and Nivolumab
Irinotecan, Fluorouracil and Leucovorin
Isatuximab Carfilzomib and Dexamethasone
Leucovorin, Fluorouracil, Cisplatin, and Trastuzumab
Loncastuximab Tesirine-lpyl
Lurbinectedin
Mirvetuximab soravtansine-gynx
Mosunetuzumab
Nivolumab
Nivolumab, Pemetrexed Disodium and Cisplatin
Obinutuzumab
Paclitaxel
Paclitaxel and Bevacizumab (Taxol-Avastin)
Panitumumab
Pembrolizumab
Pembrolizumab, Doxorubicin, and Cyclophosphamide
Pembrolizumab, Epirubicin hydrochloride, and Cyclophosphamide
Pembrolizumab, Paclitaxel, and Carboplatin
Pembrolizumab, Pemetrexed and Carboplatin
Pemetrexed and Carboplatin
Pemetrexed and Cisplatin
Polatuzumab Vedotin + Rituximab
R-Chop
R-EPOCH
Ramucirumab
Ramucirumab + Paclitaxel
Sacituzumab Govitecan
Tafasitamab-CXIX + Lenalidomide
TCH
THP
Tisotumab Vedotin
Trabectedin
Trastuzumab
Trastuzumab and Pertuzumab
Trastuzumab Deruxtecan
Tremelimumab and Durvalumab
Tremelimumab, Durvalumab, Albumin-bound paclitaxel, and Carboplatin
Tremelimumab, Durvalumab, Gemcitabine, and Carboplatin
Tremelimumab, Durvalumab, Gemcitabine, and Cisplatin
Tremelimumab, Durvalumab, Pemetrexed, and Carboplatin
Tremelimumab, Durvalumab, Pemetrexed, and Cisplatin
Trifluridine-Tipiracil and Bevacizumab